<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="(COVID-19) represents a global concern of public health caused by" exact="severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2). Its clinical manifestations are characterized by"/>
 <result pre="pictures (ranging from asymptomatic to lethal courses). The prevalence of" exact="conjunctivitis" post="in patients with COVID-19 is at present controversial. Although"/>
 <result pre="thus suggesting potential broad-spectrum applications. coronavirus disease 2019 (COVID-19) coronavirus" exact="severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) eye drop therapy treatment antiviral repurposing"/>
 <result pre="The origin of this disease is infectious, being caused by" exact="severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2), and its clinical manifestations are characterized"/>
 <result pre="of human tears and ocular surface epithelia, the appearance of" exact="conjunctivitis" post="in COVID-19 may be presumed to be not uncommon"/>
 <result pre="eyes are not the main transmission routes of SARS-CoV-2 [4]," exact="conjunctivitis" post="can be the first presenting symptom of COVID-19, before"/>
 <result pre="symptoms, such as cough and fever [5,6,7]. The prevalence of" exact="conjunctivitis" post="in patients with COVID-19 is, at present, controversial. Although"/>
 <result pre="been reported that only 0.9% of patients developed signs of" exact="conjunctivitis" post="[8], another report indicates that up to 31.6% (12"/>
 <result pre="(12 cases out of 32 patients) of hospitalized patients had" exact="conjunctivitis" post="[9]. Considering the widespread use of topical ophthalmic medications"/>
 <result pre="Roche, Genentech, South San Francisco, CA, USA) for wet age-related" exact="macular degeneration" post="(original indication: colorectal cancer). Despite the fact that specific"/>
 <result pre="sodium hypochlorite (at least 0.21%) has shown efficacy against mouse" exact="hepatitis" post="virus (a species of coronavirus) and, consequently, should also"/>
 <result pre="[19,20,21,22]. 6. Artificial Tears Considering that the prevalence of dry" exact="eye disease" post="ranges from 5 to 50% in the general population,"/>
 <result pre="leading cause of global irreversible blindness. Present estimates of global" exact="glaucoma" post="prevalence are not up-to-date and focus mainly on European"/>
 <result pre="focus mainly on European ancestry populations. The global prevalence of" exact="glaucoma" post="for the population aged 40–80 years is 3.54% and"/>
 <result pre="3.54% and rises progressively by age. Some drugs used for" exact="glaucoma" post="have been shown to affect the clinical course of"/>
 <result pre="is used in the treatment of viral infections, such as" exact="herpes simplex" post="infections [58]. Of interest, dorzolamide showed antiviral action against"/>
 <result pre="infections [58]. Of interest, dorzolamide showed antiviral action against oseltamivir-resistant" exact="influenza" post="by an in silico screening, specifically targeting mutant viral"/>
 <result pre="inhibitor of viral growth of the H3N2 virus and H1N1" exact="influenza" post="viruses and a weak inhibitor of avian H5N2 and"/>
 <result pre="viruses and a weak inhibitor of avian H5N2 and H7N1" exact="influenza" post="viruses [60]. Overall, glaucoma drugs may have a synergistic"/>
 <result pre="inhibitor of avian H5N2 and H7N1 influenza viruses [60]. Overall," exact="glaucoma" post="drugs may have a synergistic action against viral infections,"/>
 <result pre="levofloxacin, ofloxacin, which have shown efficacy against polyomavirus BK and" exact="influenza" post="virus), aminoglycosides (e.g., on Japanese encephalitis and influenza A"/>
 <result pre="against polyomavirus BK and influenza virus), aminoglycosides (e.g., on Japanese" exact="encephalitis" post="and influenza A virus infection), chloramphenicol (e.g., on human"/>
 <result pre="BK and influenza virus), aminoglycosides (e.g., on Japanese encephalitis and" exact="influenza" post="A virus infection), chloramphenicol (e.g., on human Herpesviridae family),"/>
 <result pre="as chlorcyclizine, chlorpheniramine, and diphenhydramine, have demonstrated antiviral action against" exact="hepatitis" post="C virus (HCV), filoviruses (consisting of Ebola virus, Marburg"/>
 <result pre="of antihistamines in antiviral effects appear to be associated with" exact="herpes simplex" post="virus (HSV) infection [82]. A group of Flavonoids, plant"/>
 <result pre="treatment of different ocular diseases, including allergic eye disorders, dry" exact="eye disease," post="diabetic retinopathy, macular degeneration, and cataracts [83,84]. In particular,"/>
 <result pre="different ocular diseases, including allergic eye disorders, dry eye disease," exact="diabetic retinopathy," post="macular degeneration, and cataracts [83,84]. In particular, antiviral effects"/>
 <result pre="diseases, including allergic eye disorders, dry eye disease, diabetic retinopathy," exact="macular degeneration," post="and cataracts [83,84]. In particular, antiviral effects have been"/>
 <result pre="therapy), have also shown antiviral action against HCV, Flavivirus and" exact="influenza" post="virus [85,86,87]. 10. Anti-Inflammatory Ophthalmic Preparations Another interesting category"/>
 <result pre="uveitis) or to control ocular pain (e.g., discomfort symptoms after" exact="cataract" post="surgery). Interestingly, some NSAIDs have shown antiviral action. However,"/>
 <result pre="be useful for patients with acute, presumed, and aspecific viral" exact="conjunctivitis" post="[90,91,92]. 11. Discussion and Conclusions Although systemic and topical"/>
 <result pre="some controversial and unclear data. First, a patient with this" exact="conjunctivitis" post="as an earlier symptom may have a negative conjunctival"/>
 <result pre="a recent meta-analysis on 1167 patients, the overall rate of" exact="conjunctivitis" post="appears to be 1.1% (13/1149), of which 3% (6/195)"/>
 <result pre="forms of COVID-19, respectively [93]. Nevertheless, an increasing number of" exact="conjunctivitis" post="case reports are continuously appearing in literature. Second, SARS-CoV-2"/>
 <result pre="conjunctivitis case reports are continuously appearing in literature. Second, SARS-CoV-2" exact="conjunctivitis" post="has been described as a mild follicular conjunctivitis otherwise"/>
 <result pre="Second, SARS-CoV-2 conjunctivitis has been described as a mild follicular" exact="conjunctivitis" post="otherwise indistinguishable from other viral causes [94]. In addition,"/>
 <result pre="epiphora, and mild eyelid edema. Another unresolved question is whether" exact="conjunctivitis" post="is directly related to virus infection or represents an"/>
 <result pre="an allergic immune response to the virus [95]. Generally, viral" exact="conjunctivitis" post="(of unknown origin) does not require treatment, although antibiotics,"/>
 <result pre="symptoms. Most medicines currently available for the treatment of viral" exact="conjunctivitis" post="are directed against herpes and adenovirus infections, and infectious"/>
 <result pre="other drugs for treatment and prevention during the onset of" exact="conjunctivitis" post="symptoms or a history of eye contact [96]. According"/>
 <result pre="contact [96]. According to Zhou [97], the rarity of viral" exact="conjunctivitis" post="in SARS-CoV-2 infection may exist in three interpretations. Firstly,"/>
 <result pre="ocular surface must not be ignoredLancet2020395e3910.1016/S0140-6736(20)30313-532035510 6.LiX.J.WangM.DaiJ.WangW.YangY.JinW.Novel coronavirus disease with" exact="conjunctivitis" post="and conjunctivitis as first symptom: Two cases reportChin. J."/>
 <result pre="must not be ignoredLancet2020395e3910.1016/S0140-6736(20)30313-532035510 6.LiX.J.WangM.DaiJ.WangW.YangY.JinW.Novel coronavirus disease with conjunctivitis and" exact="conjunctivitis" post="as first symptom: Two cases reportChin. J. Exp. Ophthalmol.20203810.0376/cma.j.cn.115989-20200303-00133"/>
 <result pre="Ophthalmol.20203810.0376/cma.j.cn.115989-20200303-00133 7.LiX.J.WangM.ChenC.Z.YangA.JinW.Ophthalmologists’ strategy for the prevention and control of coronavirus" exact="pneumonia" post="with conjunctivitis or with conjunctivitis as the first symptomChin."/>
 <result pre="strategy for the prevention and control of coronavirus pneumonia with" exact="conjunctivitis" post="or with conjunctivitis as the first symptomChin. J. Exp."/>
 <result pre="prevention and control of coronavirus pneumonia with conjunctivitis or with" exact="conjunctivitis" post="as the first symptomChin. J. Exp. Ophthalmol.20203827628010.3760/cma.j.issn.2095-0160.2020.0002 8.GuanW.-J.NiZ.-Y.HuY.LiangW.-H.OuC.-Q.HeJ.-X.LiuL.ShanH.LeiC.-L.HuiD.S.et al.Clinical"/>
 <result pre="activities of lactoferrinAntivir. Res.20015222523910.1016/S0166-3542(01)00195-411675140 29.KochC.ReichlingJ.SchneeleJ.SchnitzlerP.Inhibitory effect of essential oils against" exact="herpes simplex" post="virus type 2Phytomedicine200815717810.1016/j.phymed.2007.09.00317976968 30.KochC.ReichlingJ.KehmR.SharafM.M.ZentgrafH.SchneeleJ.SchnitzlerP.Efficacy of anise oil, dwarf-pine oil"/>
 <result pre="simplex Virus (HSV-I)Planta Med.20026878078310.1055/s-2002-3439712357386 32.DanaherR.J.WangC.DaiJ.MumperR.J.MillerC.S.Antiviral effects of blackberry extract against" exact="herpes simplex" post="virus type 1Oral Surg. Oral Med. Oral Pathol. Oral"/>
 <result pre="A H3N2 and Hepatitis B Virus in VitroMolecules2015205137515110.3390/molecules2003513725808155 35.LeeJ.-H.ParkJ.-S.LeeS.-W.HwangS.-Y.YoungB.-E.ChoiH.-J.Porcine epidemic" exact="diarrhea" post="virus infection: Inhibition by polysaccharide from Ginkgo biloba exocarp"/>
 <result pre="al.Vitamin D supplementation improves response to antiviral treatment for recurrent" exact="hepatitis" post="CTranspl. Int.201024435010.1111/j.1432-2277.2010.01141.x 50.Gal-TanamyM.BachmetovL.RavidA.KorenR.ErmanA.Tur-KaspaR.ZemelR.Vitamin D: An innate antiviral agent suppressing"/>
 <result pre="hepatitis CTranspl. Int.201024435010.1111/j.1432-2277.2010.01141.x 50.Gal-TanamyM.BachmetovL.RavidA.KorenR.ErmanA.Tur-KaspaR.ZemelR.Vitamin D: An innate antiviral agent suppressing" exact="hepatitis" post="C virus in human hepatocytesHepatology2011541570157910.1002/hep.2457521793032 51.HubbardG.B.HerronB.E.AndrewsJ.S.ElliottJ.H.Influence of topical and"/>
 <result pre="Mild to Moderate Dry Eye DiseaseCurr. Eye Res.2019441306131210.1080/02713683.2019.164182431283891 53.WandM.GilbertC.M.LiesegangT.J.Latanoprost and" exact="herpes simplex" post="keratitisAm. J. Ophthalmol.199912760262410.1016/S0002-9394(99)00050-110334356 54.KaufmanH.E.VarnellE.D.ThompsonH.W.Latanoprost increases the severity and recurrence"/>
 <result pre="J. Ophthalmol.199912760262410.1016/S0002-9394(99)00050-110334356 54.KaufmanH.E.VarnellE.D.ThompsonH.W.Latanoprost increases the severity and recurrence of herpetic" exact="keratitis" post="in the rabbitAm. J. Ophthalmol.199912753153610.1016/S0002-9394(99)00089-610334345 55.ParkH.G.ChoiS.A Case of Herpetic"/>
 <result pre="of 0.015% Tafluprost Eye DropsJ. Korean Ophthalmol. Soc.201354195010.3341/jkos.2013.54.12.1950 56.KrollD.M.SchumanJ.S.Reactivation of" exact="herpes simplex" post="virus keratitis after initiating bimatoprost treatment for glaucomaAm. J."/>
 <result pre="Eye DropsJ. Korean Ophthalmol. Soc.201354195010.3341/jkos.2013.54.12.1950 56.KrollD.M.SchumanJ.S.Reactivation of herpes simplex virus" exact="keratitis" post="after initiating bimatoprost treatment for glaucomaAm. J. Ophthalmol.200213340140310.1016/S0002-9394(01)01360-511860979 57.YangH.S.ParkH.G.ChoiS.Reactivation"/>
 <result pre="Virus Prophylaxis Following Kidney TransplantationJAMA2014312210610.1001/jama.2014.1472125399012 65.KimH.LeeM.-K.KoJ.ParkC.-J.KimM.JeongY.HongS.VaraniG.ChoiB.-S.Aminoglycoside antibiotics bind to the" exact="influenza" post="a virus RNA promoterMol. BioSyst.201282857285910.1039/c2mb25333j22990985 66.TopnoR.KhanS.A.ChowdhuryP.MahantaJ.Pharmacodynamics of aminoglycosides and"/>
 <result pre="promoterMol. BioSyst.201282857285910.1039/c2mb25333j22990985 66.TopnoR.KhanS.A.ChowdhuryP.MahantaJ.Pharmacodynamics of aminoglycosides and tetracycline derivatives against Japanese" exact="encephalitis" post="virusAsian Pac. J. Trop. Med.2016924124610.1016/j.apjtm.2016.01.03326972394 67.ZegarelliE.V.BudowskyJ.SilversH.F.KutscherA.H.Chloramphenicol in Treatment of"/>
 <result pre="EsterAntimicrob. Agents Chemother.19781319920410.1128/AAC.13.2.199206201 73.SchloerS.GoretzkoJ.KühnlA.BrunotteL.LudwigS.RescherU.The clinically licensed antifungal drug itraconazole inhibits" exact="influenza" post="virus in vitro and in vivoEmerg. Microbes Infect.20198809310.1080/22221751.2018.155970930866762 74.TakamuraE.UchioE.EbiharaN.OhnoS.OhashiY.OkamotoS.KumagaiN.SatakeY.ShojiJ.NakagawaY.et"/>
 <result pre="allergic conjunctival diseases 2017Allergol. Int.20176622022910.1016/j.alit.2016.12.00428209324 75.LeonardiA.BogackaE.FauquertJ.-L.KowalskiM.L.GroblewskaA.Jedrzejczak-CzechowiczM.DoanS.MarmouzF.DemolyP.DelgadoL.Ocular allergy: Recognizing and diagnosing" exact="hypersensitivity" post="disorders of the ocular surfaceAllergy2012671327133710.1111/all.1200922947083 76.BronA.J.De PaivaC.S.ChauhanS.K.BoniniS.GabisonE.E.JainS.KnopE.MarkoulliM.OgawaY.PerezV.et al.TFOS DEWS"/>
 <result pre="of the antihistamine chlorcyclizine and related compounds for treatment of" exact="hepatitis" post="C virus infectionSci. Transl. Med.20157282ra4910.1126/scitranslmed.3010286 79.XuW.XiaS.PuJ.WangQ.LiP.LuL.JiangS.The Antihistamine Drugs Carbinoxamine"/>
 <result pre="using in vitro model of DENV3-induced RBL-2H3 cellsBiosci. Rep.20193910.1042/BSR20181273 82.ZawarV.P.GodseK.SankalechaS.Chronic" exact="urticaria" post="associated with recurrent genital herpes simplex infection and success"/>
 <result pre="DENV3-induced RBL-2H3 cellsBiosci. Rep.20193910.1042/BSR20181273 82.ZawarV.P.GodseK.SankalechaS.Chronic urticaria associated with recurrent genital" exact="herpes simplex" post="infection and success of antiviral therapy—A report of two"/>
 <result pre="on human virusesJ. Med. Virol.198515717910.1002/jmv.18901501102981979 85.RabieR.MumtazK.RennerE.L.Efficacy of antiviral therapy for" exact="hepatitis" post="C after liver transplantation with cyclosporine and tacrolimus: A"/>
 <result pre="of indometacin, prostaglandin E2 and interferon on the multiplication of" exact="herpes simplex" post="virus type 1 in human lymphoid cellsAntivir. Res.19901416117210.1016/0166-3542(90)90032-31964373 89.HigakiS.WatanabeK.ItahashiM.ShimomuraY.Cyclooxygenase"/>
 <result pre="topical steroid in presumed viral conjunctivitisBr. J. Ophthalmol.2011951299130310.1136/bjo.2010.18862321252084 92.KhanJ.MackH.G.Management of" exact="conjunctivitis" post="during the COVID-19 pandemic 2020Aust. J. Gen. Pract.20204910.31128/AJGP-COVID-1832362106 93.LoffredoL.PacellaF.PacellaE.TiscioneG.OlivaA.VioliF.Conjunctivitis"/>
 <result pre="activity of Australian tea tree oil and eucalyptus oil against" exact="herpes simplex" post="virus in cell cultureDie Pharm.200156343347 110.BishopC.D.Antiviral Activity of the"/>
 <result pre="have a broad-spectrum action, possibly including inhibition of replication/diffusion of" exact="severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) on the ocular surface. Abbreviations were"/>
 <result pre="viruses (notable for its ability to infect M. tuberculosis); Mouse" exact="hepatitis" post="virus (MHV); Encephalomyocarditis virus (EMC).H(X)N(Y): Influenza A viruses. Based"/>
 <result pre="classified into different subtypes: H1N1 (the common cause of human" exact="influenza" post="and generally associated with the Spanish flu), H3N2 (commonly"/>
 <result pre="or seasonal H3N2 flu), H5N2 or H7N1 (generally associated with" exact="avian influenza" post="virus or bird flu virus). e.g., -exempli gratia."/>
 <result pre="seasonal H3N2 flu), H5N2 or H7N1 (generally associated with avian" exact="influenza" post="virus or bird flu virus). e.g., -exempli gratia."/>
</results>
